Holdings of Boxer Capital Management, LLC
45 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 68.1 % of the equity sleeve
Sector breakdown
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 44 | 685.6M $ | 96.85 % |
| 2 | FR | 1 | 22.3M $ | 3.15 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Tango Therapeutics Inc | 10,876,219 | 227.5M $ | |
| 2 | Kodiak Sciences Inc | 1,361,000 | 51.9M $ | |
| 3 | Revolution Medicines Inc | 500,000 | 48.6M $ | |
| 4 | Kymera Therapeutics Inc | 329,100 | 27.4M $ | |
| 5 | Celcuity Inc | 225,000 | 25.7M $ | |
| 6 | Surrozen Inc | 766,318 | 22.3M $ | |
| 7 | Abivax SA | 200,000 | 22.3M $ | |
| 8 | Terns Pharmaceuticals Inc | 375,000 | 19.8M $ | |
| 9 | Vaxcyte Inc | 325,000 | 18.9M $ | |
| 10 | Capricor Therapeutics Inc | 590,000 | 17.9M $ | |
| 11 | Protagonist Therapeutics Inc | 170,000 | 17.9M $ | |
| 12 | Vir Biotechnology Inc | 1,866,000 | 16.7M $ | |
| 13 | Corvus Pharmaceuticals Inc | 1,100,000 | 16.1M $ | |
| 14 | Praxis Precision Medicines Inc | 46,457 | 15M $ | |
| 15 | PTC Therapeutics Inc | 200,000 | 13.6M $ | |
| 16 | Precigen Inc | 3,500,000 | 13.5M $ | |
| 17 | Amylyx Pharmaceuticals Inc | 800,000 | 11.1M $ | |
| 18 | Opus Genetics Inc | 2,250,000 | 10.2M $ | |
| 19 | Corcept Therapeutics Inc | 250,000 | 10.1M $ | |
| 20 | Replimune Group Inc | 1,175,000 | 9M $ | |
| 21 | Cogent Biosciences Inc | 225,000 | 8.7M $ | |
| 22 | Palisade Bio Inc | 4,799,875 | 8.4M $ | |
| 23 | Soleno Therapeutics Inc | 200,000 | 6.7M $ | |
| 24 | Allogene Therapeutics Inc | 2,725,000 | 6.6M $ | |
| 25 | Cytokinetics Inc | 100,000 | 6.6M $ | |
| 26 | Contineum Therapeutics Inc | 494,000 | 6.5M $ | |
| 27 | Apogee Therapeutics Inc | 70,000 | 5.9M $ | |
| 28 | Relmada Therapeutics Inc | 842,106 | 5.9M $ | |
| 29 | AVALO THERAPEUTICS INC | 300,000 | 4.5M $ | |
| 30 | INOVIO PHARMACEUTICALS INC | 2,370,122 | 4.1M $ | |
| 31 | Structure Therapeutics Inc | 75,000 | 3.6M $ | |
| 32 | Sarepta Therapeutics Inc | 150,000 | 3.3M $ | |
| 33 | Ocular Therapeutix Inc | 350,000 | 3M $ | |
| 34 | AN2 Therapeutics Inc | 749,035 | 2.6M $ | |
| 35 | CLENE INC | 477,515 | 2.4M $ | |
| 36 | ORIC Pharmaceuticals Inc | 176,500 | 2.2M $ | |
| 37 | Solid Biosciences Inc | 300,000 | 2.2M $ | |
| 38 | Invivyd Inc | 1,500,000 | 2M $ | |
| 39 | LB Pharmaceuticals Inc | 70,000 | 1.7M $ | |
| 40 | Karyopharm Therapeutics Inc | 302,536 | 1.7M $ | |
| 41 | Nurix Therapeutics Inc | 100,000 | 1.6M $ | |
| 42 | Upstream Bio Inc | 150,000 | 1.4M $ | |
| 43 | PepGen Inc | 272,892 | 483K $ | |
| 44 | KalVista Pharmaceuticals Inc | 20,400 | 410.7K $ | |
| 45 | REGENXBIO Inc | 15,000 | 125.7K $ | |